Pain & Central Nervous System Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain & Central Nervous System Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
University of Texas Medical Branch at Galveston
Experiments could lead to new treatments for neuroblastoma
September 1st, 2008
Neuroblastoma is one of the most devastating diagnoses a child can receive. The cancer's victims average 2 years old when the disease is detected, most often by a parent feeling a lump in a child's abdomen. By then, the disease has often reached an advanced stage, and advanced neuroblastoma kills more than 50 percent of the children in whom it develops, despite aggressive treatment with surgery, chemotherapy and radiation. Now, though, University of Texas Medical Branch at Galveston researchers believe they've found a critical weakness in the deadly cancer — one that could lead to the development of a lifesaving therapy. In a paper published this week in the...
Source: Pain & Central Nervous System Week (2008-09-01)
|
